-
Big Movers in Focus: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Intercontinental Hotels Group plc (NYSE:IHG), AVG Technologies N.V. (NYSE:AVG), Hanesbrands (NYSE:HBI), Majesco Entertainment (NASDAQ:COOL)
Teva Pharmaceutical Industries Ltd. and Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announce that the companies have entered into an exclusive license agreement for EP-3102, Eagle’s bendamustine hydrochloride (HCl) rapid infusion product for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL). On Tuesday shares of Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) closed at $26.10. Intercontinental…
-
Must Watch These 5 Stocks: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), MER Telemanagement Solutions (NASDAQ:MTSL), Olin Corp. (NYSE:OLN), AOL Inc. (NYSE:AOL), iRobot Corporation (NASDAQ:IRBT)
Teva Pharmaceutical Industries Ltd and Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) said the companies have entered into an exclusive license agreement for EP-3102, Eagle’s bendamustine hydrochloride rapid infusion product for the treatment of chronic lymphocytic leukemia or CLL and indolent B-cell non-Hodgkin lymphoma or NHL. On Tuesday shares of Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) closed at $26.10. On…
-
Stocks Getting Investor’s Attention: Twenty-First Century Fox (NASDAQ:FOXA), Rite Aid (NYSE:RAD), Owens & Minor (NYSE:OMI), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Noble Corp (NYSE:NE)
Twenty-First Century Fox, Inc. (NASDAQ:FOXA) said Wednesday its net income climbed in the fiscal second quarter after it sold off its Sky Italia and Sky Deutschland businesses. During the quarter the company spent $1.5 billion buying back its stock, reducing its shares outstanding about 6 percent year over year. On Wednesday shares of Twenty-First Century…
-
Market Alert: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Microsoft Corporation (NASDAQ:MSFT), Watts Water Technologies (NYSE:WTS), Wolverine World Wide Inc. (NYSE:WWW), Sealed Air (NYSE:SEE)
Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) said that Board of Directors has approved a change in the Company’s fiscal year end to December 31. The change will result in a stub period from October 1, 2014 to December 31, 2014, and as a result of the change, the fiscal year 2015 will end on December 31, 2015.…
-
Top Stocks: Pandora Media Inc (NYSE:P), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Turtle Beach Corporation (NASDAQ:HEAR), Premier Financial Bancorp Inc. (NASDAQ:PFBI), Enzymotec (NASDAQ:ENZY)
Pandora Media Inc (NYSE:P), the leading Internet radio service, announced on 13 January that Alan Schanzer has joined the company as Senior Vice President, Agency and Advertiser Development. Schanzer will report directly to Chief Revenue Officer John Trimble. On Friday shares of Pandora Media Inc (NYSE:P) closed at $17.57. Company’s sales growth for last 5…
-
Healthcare Bulls: The Medicines Company (NASDAQ:MDCO), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Retractable Technologies (NYSEMKT:RVP), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Agile Therapeutics (NASDAQ:AGRX)
The Medicines Company (NASDAQ:MDCO) on 7 January announced that it has priced its private offering of $350 million in aggregate principal amount of its convertible senior notes due 2022, an increase from the $300 million in aggregate principal amount previously announced. On Wednesday shares of The Medicines Company (NASDAQ:MDCO) closed at $26.02. Company’s sales growth…
-
Top Morning News: Ford Motor Company (NYSE:F), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), BCE Inc. (NYSE:BCE), Tech Data Corp. (NASDAQ:TECD), Taiwan Semiconductor Manufacturing (NYSE:TSM)
On 16 January Ford Motor Company (NYSE:F) introduced new autos to Myanmar market American auto maker Ford has introduced three new models to the Myanmar market through its local distributor Capital Automotive. On Wednesday shares of Ford Motor Company (NYSE:F) closed at $14.97. Company’s sales growth for last 5 years was 0.50% and EPS growth…
-
Watch 5 Stocks: DryShips (NASDAQ:DRYS), Talisman Energy Inc. (NYSE:TLM), FreeSeas Inc. (NASDAQ:FREE), Energy XXI Ltd (NASDAQ:EXXI), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)
DryShips Inc. (NASDAQ:DRYS) announced on 22 December the results of its 2014 Annual General Meeting of Shareholders. The proposals approved and adopted at the Meeting are the election of Mr. George Economou, Mr. Harry Kerames and Mr. Vassilis Karamitsanis as Class A Directors of the Company to serve until the 2017 Annual General Meeting of…
-
Why Investors Are Watching: Marinus Pharmaceuticals (NASDAQ:MRNS), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Universal Health Services (NYSE:UHS), First Mid-Illinois Bancshares (NASDAQ:FMBH), Ericsson (NASDAQ:ERIC)
On December 3, 2014, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) entered into a First Amendment to Loan and Security Agreement (the “Loan Agreement”) with Square 1 Bank (the “Amendment”). The Amendment increases the term loan availability under the Loan Agreement from $2.0 million to $12.0 million. In addition to the $2.0 million term loan currently outstanding, borrowed…
-
Why Traders Are Watching: NeuroDerm (NASDAQ:NDRM), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), AECOM Technology Corporation (NYSE:ACM), ShoreTel (NASDAQ:SHOR), Rush Enterprises (NASDAQ:RUSHB)
On 30 December NeuroDerm Ltd. (NASDAQ:NDRM) announced that continuous, subcutaneous delivery of the company’s proprietary liquid levodopa/carbidopa (LD/CD) product candidates, ND0612H and ND0612L, led to clinically-significant plasma levodopa levels. These results suggest that the high dose version, ND0612H, intended for severe Parkinson’s disease patients, may provide an effective therapy alternative to current treatments requiring surgery.…